OTC ACYCLOVIR STATUS UNDER MEDICAID AND MEDICARE SHOULD BE EXPLORED
This article was originally published in The Tan Sheet
Executive Summary
OTC ACYCLOVIR STATUS UNDER MEDICAID AND MEDICARE SHOULD BE EXPLORED by FDA in conjunction with the review of Burroughs Wellcome's Rx-to-OTC switch application for Zovirax, FDA Antiviral Drugs Advisory Committee member Mark Smith, MD, vice president of the Henry J. Kaiser Family Foundation, suggested.